Robert M. Tynebor

514 total citations
9 papers, 168 citations indexed

About

Robert M. Tynebor is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Robert M. Tynebor has authored 9 papers receiving a total of 168 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 6 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Robert M. Tynebor's work include Synthesis and biological activity (4 papers), HIV Research and Treatment (3 papers) and HIV/AIDS drug development and treatment (3 papers). Robert M. Tynebor is often cited by papers focused on Synthesis and biological activity (4 papers), HIV Research and Treatment (3 papers) and HIV/AIDS drug development and treatment (3 papers). Robert M. Tynebor collaborates with scholars based in United States and China. Robert M. Tynebor's co-authors include S. Natarajan, Meng‐Hsin Chen, Thomas J. Tucker, Ming‐Tain Lai, Theresa M. Williams, James E. Thompson, Catherine E. Fitzgerald, James B. Doherty, Stephen J. O’Keefe and Daria J. Hazuda and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Tetrahedron Letters and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Robert M. Tynebor

9 papers receiving 161 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert M. Tynebor United States 8 84 72 63 57 22 9 168
Sandhya Rahematpura United States 8 47 0.6× 70 1.0× 70 1.1× 88 1.5× 14 0.6× 8 185
Jason G. Weatherhead United States 7 223 2.7× 110 1.5× 80 1.3× 92 1.6× 23 1.0× 10 347
Yi-Fei Gong United States 4 79 0.9× 60 0.8× 59 0.9× 20 0.4× 15 0.7× 4 139
Gwen Carver United States 6 66 0.8× 41 0.6× 57 0.9× 65 1.1× 7 0.3× 6 158
Karen Holmes United States 7 66 0.8× 43 0.6× 57 0.9× 65 1.1× 8 0.4× 7 178
Jill R. Cowan United States 6 145 1.7× 136 1.9× 125 2.0× 54 0.9× 58 2.6× 6 305
Steve S. Carroll United States 9 68 0.8× 131 1.8× 58 0.9× 138 2.4× 38 1.7× 12 288
Valerio Gatti Italy 7 174 2.1× 90 1.3× 48 0.8× 40 0.7× 20 0.9× 7 301
Lee T. Schaller United States 6 148 1.8× 136 1.9× 125 2.0× 64 1.1× 58 2.6× 7 313

Countries citing papers authored by Robert M. Tynebor

Since Specialization
Citations

This map shows the geographic impact of Robert M. Tynebor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Tynebor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Tynebor more than expected).

Fields of papers citing papers by Robert M. Tynebor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert M. Tynebor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Tynebor. The network helps show where Robert M. Tynebor may publish in the future.

Co-authorship network of co-authors of Robert M. Tynebor

This figure shows the co-authorship network connecting the top 25 collaborators of Robert M. Tynebor. A scholar is included among the top collaborators of Robert M. Tynebor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert M. Tynebor. Robert M. Tynebor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Tynebor, Robert M., et al.. (2013). Novel Method of Synthesizing Various Five Membered Heterocycles from an Aryl Tribromomethyl Group. Synthetic Communications. 43(14). 1902–1908. 7 indexed citations
2.
Tynebor, Robert M., Meng‐Hsin Chen, S. Natarajan, et al.. (2012). Synthesis and biological activity of pyridopyridazin-6-one p38α MAP kinase inhibitors. Part 2. Bioorganic & Medicinal Chemistry Letters. 22(18). 5979–5983. 14 indexed citations
3.
Gomez, Robert, Samson M. Jolly, Theresa M. Williams, et al.. (2011). Design and synthesis of pyridone inhibitors of non-nucleoside reverse transcriptase. Bioorganic & Medicinal Chemistry Letters. 21(24). 7344–7350. 22 indexed citations
4.
Tynebor, Robert M., Meng‐Hsin Chen, S. Natarajan, et al.. (2010). Synthesis and biological activity of pyridopyridazin-6-one p38 MAP kinase inhibitors. Part 1. Bioorganic & Medicinal Chemistry Letters. 21(1). 411–416. 15 indexed citations
5.
Tynebor, Robert M., Meng‐Hsin Chen, S. Natarajan, et al.. (2010). Synthesis and biological activity of 2H-quinolizin-2-one based p38α MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(9). 2765–2769. 11 indexed citations
6.
Lai, Ming‐Tain, Meiqing Lu, Peter J. Felock, et al.. (2010). Distinct Mutation Pathways of Non-Subtype B HIV-1 duringIn VitroResistance Selection with Nonnucleoside Reverse Transcriptase Inhibitors. Antimicrobial Agents and Chemotherapy. 54(11). 4812–4824. 33 indexed citations
7.
Lai, Ming‐Tain, Vandna Munshi, Sinoeun Touch, et al.. (2009). Antiviral Activity of MK-4965, a Novel Nonnucleoside Reverse Transcriptase Inhibitor. Antimicrobial Agents and Chemotherapy. 53(6). 2424–2431. 31 indexed citations
8.
Natarajan, S., Meng‐Hsin Chen, Stephen T. Heller, et al.. (2006). Synthesis of the 2H-quinolizin-2-one scaffold via a stepwise acylation—intramolecular annulation strategy. Tetrahedron Letters. 47(29). 5063–5067. 21 indexed citations
9.
Lin, Songnian, Xudong Geng, Chuanxing Qu, et al.. (2000). Synthesis of highly potent second-generation taxoids through effective kinetic resolution coupling of racemic ?-lactams with baccatins. Chirality. 12(5-6). 431–441. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026